IUCrJ (Sep 2014)

Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1

  • Ho-Hsien Lee,
  • Irene Cherni,
  • HongQi Yu,
  • Raimund Fromme,
  • Jeffrey D. Doran,
  • Ingo Grotjohann,
  • Michele Mittman,
  • Shibom Basu,
  • Arpan Deb,
  • Katerina Dörner,
  • Andrew Aquila,
  • Anton Barty,
  • Sébastien Boutet,
  • Henry N. Chapman,
  • R. Bruce Doak,
  • Mark S. Hunter,
  • Daniel James,
  • Richard A. Kirian,
  • Christopher Kupitz,
  • Robert M. Lawrence,
  • Haiguang Liu,
  • Karol Nass,
  • Ilme Schlichting,
  • Kevin E. Schmidt,
  • M. Marvin Seibert,
  • Robert L. Shoeman,
  • John C. H. Spence,
  • Francesco Stellato,
  • Uwe Weierstall,
  • Garth J. Williams,
  • Chunhong Yoon,
  • Dingjie Wang,
  • Nadia A. Zatsepin,
  • Brenda G. Hogue,
  • Nobuyuki Matoba,
  • Petra Fromme,
  • Tsafrir S. Mor

DOI
https://doi.org/10.1107/S2052252514014900
Journal volume & issue
Vol. 1, no. 5
pp. 305 – 317

Abstract

Read online

CTB-MPR is a fusion protein between the B subunit of cholera toxin (CTB) and the membrane-proximal region of gp41 (MPR), the transmembrane envelope protein of Human immunodeficiency virus 1 (HIV-1), and has previously been shown to induce the production of anti-HIV-1 antibodies with antiviral functions. To further improve the design of this candidate vaccine, X-ray crystallography experiments were performed to obtain structural information about this fusion protein. Several variants of CTB-MPR were designed, constructed and recombinantly expressed in Escherichia coli. The first variant contained a flexible GPGP linker between CTB and MPR, and yielded crystals that diffracted to a resolution of 2.3 Å, but only the CTB region was detected in the electron-density map. A second variant, in which the CTB was directly attached to MPR, was shown to destabilize pentamer formation. A third construct containing a polyalanine linker between CTB and MPR proved to stabilize the pentameric form of the protein during purification. The purification procedure was shown to produce a homogeneously pure and monodisperse sample for crystallization. Initial crystallization experiments led to pseudo-crystals which were ordered in only two dimensions and were disordered in the third dimension. Nanocrystals obtained using the same precipitant showed promising X-ray diffraction to 5 Å resolution in femtosecond nanocrystallography experiments at the Linac Coherent Light Source at the SLAC National Accelerator Laboratory. The results demonstrate the utility of femtosecond X-ray crystallography to enable structural analysis based on nano/microcrystals of a protein for which no macroscopic crystals ordered in three dimensions have been observed before.

Keywords